In the topsy-turvy world of 2026, where the “Defense Production Act” is apparently the go-to tool for propping up 19th-century fuel sources and the Lincoln Memorial is getting a fancy new promenade, the stock market has decided to play a game of “Good News is Actually Terrifying.” On Friday, June 5, the U.S. economy added a staggering 172,000 jobs—more than double the 80,000 that boring economists had predicted. Naturally, Wall Street reacted with the grace of a startled cat in a room full of rocking chairs.
The S&P 500 (-1.60%) tumbled to 7,463.24, while the tech-heavy NASDAQ (-2.65%) took a 26,122.36-point nose dive. Even the Dow Jones Industrial Average (-0.74%), which usually enjoys a good old-fashioned jobs boost, slipped to 51,182.31. The reason? Investors are deathly afraid that if Americans keep having the audacity to be employed, the Federal Reserve might actually raise interest rates in December. It’s a classic case of “the economy is too healthy, so we must punish the stocks.”
President Donald Trump, ever the observant market commentator, took to Truth Social to express his profound bewilderment. “Stocks should go up, not down,” he posted, seemingly puzzled that the “massive jobs boost” he helped create resulted in a sea of red on his Bloomberg terminal. It’s almost as if the market’s relationship with reality has been replaced by a complex algorithm that views human prosperity as a precursor to a rate-hike-induced apocalypse.
Coal: Because Nothing Says ‘Defense’ Like Carbon
While the broader market was busy panic-selling, the administration decided to double down on its “Beautiful, Clean Coal” initiative. Invoking the Defense Production Act—a power usually reserved for things like, you know, national emergencies or wars—Trump announced a $700 million plan to boost the coal industry. The package includes $425 million to upgrade 13 existing coal-fired power plants and $75 million for a new export terminal in Oakland, California. Because if there’s one thing Oakland is known for, it’s its burning desire to be a hub for 1800s energy exports.
The immediate reaction in the coal sector was a brief, euphoric spike. On Thursday, BTU (+4.0%)—Peabody Energy—and HNRG (+4.47%)—Hallador Energy—were the darlings of the trading floor. However, the Friday “jobs-are-bad” sell-off eventually caught up with them. By midday Friday, BTU (-7.63%) had surrendered all its gains and then some, trading around $31.22. It turns out that even the Defense Production Act can’t defend a stock price against a 70% probability of a Fed rate hike.
Analysts at UBS recently lowered their price target for BTU to $32, maintaining a “Neutral” rating. It seems the “structural policy tailwinds” of reduced royalty rates and tax credits are being weighed against the minor detail that the rest of the world is still trying to figure out how to breathe. But hey, at least 14,000 jobs are “protected,” even if the stock price is currently unprotected from gravity.
The 250% Solution: Pharmaceutical Tariffs and Reshoring
If you thought the coal announcement was bold, wait until you hear about the plan for your medicine cabinet. Trump has renewed his threat to impose pharmaceutical tariffs that could eventually reach a staggering 250%. “We want pharmaceuticals made in our country,” he told CNBC, with the casual tone of someone suggesting we order pizza. The plan is to start with “small” tariffs and ramp them up to 150% and then 250% over the next 18 months.
The market reaction has been a mixture of frantic capital investment and quiet weeping from healthcare CFOs. LLY (+0.05%)—Eli Lilly—has already pledged $50 billion to U.S. manufacturing to get ahead of the “Tariff Bombshell.” Meanwhile, foreign giants like Novartis and Roche are staring down potential annual losses in the hundreds of millions. The S&P 500 Health Care Sector (-1.1%) is currently having its worst year relative to the broader market in 25 years, down nearly 12% year-over-year.
The logic is simple: tax the life-saving drugs until they are made in Ohio. The potential side effect? Skyrocketing prescription costs for millions of Americans. But as the administration frames it, this is a “win for small businesses” and a blow to the “Green New Scam.” It’s a bold strategy to lower the cost of living by making everything imported cost three times as much, but who are we to question the “single largest deregulatory action in American history”?
Trade Deals, Promenades, and the India Connection
Amidst the threats to the UK over “forced labor” and the 60 other trade partners currently in the crosshairs, there is one bright spot: India. Trump has shown renewed confidence in a long-anticipated U.S.-India trade deal, aiming for a $500 billion trade target by 2030. Investors looking to play this potential bromance have been piling into the EPI (+0.05%)—WisdomTree India Earnings Fund—which weights its holdings by earnings rather than market cap. It’s a refreshing change of pace—a trade policy that involves actually trading things rather than just threatening to tax them into oblivion.
And let’s not forget the “Promenade.” In a move that surely has the DOW‘s industrial components salivating, Trump announced a plan to build a promenade connecting the Lincoln Memorial to the Potomac. While the price tag for this architectural flourish wasn’t immediately clear, the Senate Republicans did manage to pass a $70 billion immigration bill this week, proving that there is always money in the banana stand—or, in this case, the federal budget—for large-scale projects.
Conclusion: The Volatility is the Policy
As we head into the weekend, the message from the markets is clear: they have no idea what to do with a healthy economy and a President who views the Defense Production Act as a venture capital fund for fossil fuels. With the VIX (+2.60%)—the market’s “fear gauge”—creeping up to 15.80, the only certainty is that next week will bring another round of “Stocks Should Go Up” posts and perhaps a tariff on imported tea just to keep the UK on its toes.
For now, investors are left to ponder the irony of a market that crashes on good employment data while the government spends $700 million to ensure that the future of American energy looks exactly like the 1920s. But hey, at least the Lincoln Memorial will have a nice walkway. You’ll need somewhere pleasant to stroll while you wait for your 250%-taxed insulin to arrive.
DISCLAIMER: We read Trump’s posts so you don’t have to. This is comedy meets market data, not financial advice. Not political advice either – we just like charts and chaos.
Elana Harper is a seasoned financial editor and market analyst with over a decade of experience covering global equities, economic trends, and corporate earnings. Known for her sharp insights, Elana specializes in making complex financial topics accessible to a broad audience. She now serves as the Senior Financial Editor at Stock Market Watch, where she oversees daily market coverage and political commentary.